What Does Tarveda Therapeutics Do?

Total employees35
HeadquartersWatertown
Founded2011

Tarveda Therapeutics was a clinical-stage biopharmaceutical company dedicated to the discovery and development of Pentarin® miniature drug conjugates. These novel therapeutics were designed to deeply penetrate solid tumors and release their potent anti-cancer payloads directly at the site of disease, aiming to improve efficacy and reduce systemic toxicity. Tarveda's platform sought to overcome the limitations of traditional antibody-drug conjugates by creating smaller, more targeted molecules. The company advanced multiple candidates into clinical development for various oncology indications. In November 2020, Tarveda Therapeutics was acquired by Shattuck Labs.

Where Is Tarveda Therapeutics's Headquarters?

Tarveda Therapeutics officeTarveda Therapeutics officeTarveda Therapeutics officeTarveda Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters served as the primary center for Tarveda's operations, including pioneering research and development of its Pentarin® platform, managing clinical trials, and housing all corporate and administrative functions prior to its acquisition.

Notable Features:

The facility was likely equipped with state-of-the-art laboratory facilities necessary for advanced biopharmaceutical research, drug discovery, and preclinical development, alongside modern office spaces designed to foster collaboration among scientific and corporate teams.

Work Culture:

As a clinical-stage biotechnology company, Tarveda Therapeutics likely fostered a dynamic, fast-paced, and innovative work culture. This typically involved a strong emphasis on scientific rigor, close collaboration between research, clinical, and corporate departments, and a shared, mission-driven focus on developing impactful cancer therapies for patients with unmet medical needs.

HQ Significance:

The Watertown headquarters was crucial as the birthplace of Tarveda's innovative Pentarin® platform and the nerve center for its drug development programs. Its location within the Boston biotech hub provided access to talent, resources, and a collaborative scientific community.

Values Reflected in HQ: The headquarters' setup likely mirrored Tarveda's core values: scientific excellence, cutting-edge innovation in drug design, a strong commitment to addressing challenging cancers, and efficient, collaborative execution.

Location:

Prior to its acquisition, Tarveda Therapeutics's operational footprint was primarily concentrated in the United States, with its research, drug development, and clinical trial management largely orchestrated from its US headquarters in Massachusetts. While its therapeutic candidates were developed with the potential for global impact on cancer patients, its physical operational presence was mainly US-based. Global activities would have included collaborations or clinical trial sites in other regions as part of its development programs.

Street Address:

134 Coolidge Avenue

City:

Watertown

State/Province:

MA

Country:

USA

Where Else Does Tarveda Therapeutics Operate Around the World?

N/A

Address: Tarveda Therapeutics primarily operated from its headquarters in Watertown, MA.

The company's focus was consolidated at its main research and corporate headquarters to streamline development efforts.

Buying Intent Signals for Tarveda Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Tarveda Therapeutics? Meet the Executive Team

As of April 2025, Tarveda Therapeutics' leadership includes:

Drew Fromkin - President and Chief Executive Officer (Former)
Brian Roberts - Chief Financial Officer (Former)
Jeffrey Bloss, M.D. - Chief Medical Officer (Former)
Guido Lanza, Ph.D. - Chief Technology Officer (Former)
Mark Bilodeau, Ph.D. - Senior Vice President, Chemistry (Former)

Who's Investing in Tarveda Therapeutics?

Tarveda Therapeutics has been backed by several prominent investors over the years, including:

Novo Holdings A/S
New Enterprise Associates (NEA)
Flagship Pioneering
NanoDimension
Versant Ventures
Kurma Partners
Brace Pharma Capital
SV Health Investors
Pivotal bioVenture Partners
NantCapital
Pharmstandard International S.A.

What Leadership Changes Has Tarveda Therapeutics Seen Recently?

Hire0
Exits0

Tarveda Therapeutics was acquired by Shattuck Labs in November 2020. Consequently, its executive team transitioned, and the company ceased independent operations. There have been no new hires or exits attributable to Tarveda Therapeutics as an independent entity in the last 12 months. The most significant recent executive event was the dissolution of its leadership team post-acquisition.

Departures

Former Tarveda Therapeutics Executive Team, The executive team of Tarveda Therapeutics departed their roles with the company upon its acquisition by Shattuck Labs in November 2020, as part of the integration process.

What Technology (Tech Stack) Is Used byTarveda Therapeutics?

Discover the tools Tarveda Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Tarveda Therapeutics Email Formats and Examples

Prior to its acquisition and cessation of independent operations, Tarveda Therapeutics likely used standard corporate email formats. Common patterns in the biotech industry include [first_initial][last]@[companydomain].com or [first].[last]@[companydomain].com. The domain tarveda.com is no longer active for email.

flast@tarveda.com (example: jdoe@tarveda.com)

Format

jdoe@tarveda.com

Example

0%

Success rate

What's the Latest News About Tarveda Therapeutics?

PR Newswire (Shattuck Labs)November 18, 2020

Shattuck Labs Announces Acquisition of Tarveda Therapeutics, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, announced its acquisition of Tarveda Therapeutics, Inc. This strategic move was aimed at enhancing Shattuck's pipeline with Tarveda's innovative Pentarin® platform and its lead clinical candidate, PEN-866, designed for treating solid tumors....more

Business Wire (Tarveda Therapeutics)February 12, 2019

Tarveda Therapeutics Completes $30 Million Series D Financing Co-led by Pivotal bioVenture Partners and NantCapital

Tarveda Therapeutics announced the successful completion of a $30 million Series D financing round. The proceeds were designated for advancing its lead Pentarin® clinical candidate, PEN-866, through clinical trials and for the continued development of its proprietary Pentarin platform for creating targeted miniature drug conjugates....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Tarveda Therapeutics, are just a search away.